Archive · 30 Jul 2026
Torrent Pharma Q1 FY27 Profit Hits ₹566 Crore
Torrent Pharmaceuticals, a drug company in Mumbai, said it made a profit of ₹566 crore in the first part of its 2027 financial year.
Its sales grew 55% to ₹4,921 crore, but the profit before taxes fell a little from the previous year.
The company had extra costs of ₹21 crore because it bought another firm, had a fire, and paid severance.
An independent director, Ameera Shah, will finish her job on 1 August 2026.
The company shared these numbers to keep investors informed.
Net profit rose to ₹566 crore in Q1 FY27.
Revenue increased 55% to ₹4,921 crore from ₹3,178 crore a year earlier.
Profit before tax fell slightly to ₹733 crore from ₹738 crore.
Exceptional items of ₹21 crore stemmed from JBCPL acquisition, fire write‑off, and severance.
Independent Director Ameera Shah’s term ends on 1 August 2026.
- Who
- Torrent Pharmaceuticals Limited
- What
- reported first‑quarter fiscal 2027 financial results
- When
- quarter ended 30 June 2026
- Where
- Mumbai, India
- Why
- to disclose its financial performance to shareholders and the market
- Net profit
- ₹566 crore
- Revenue
- ₹4,921 crore
- Profit before tax
- ₹733 crore
- Exceptional items
- ₹21 crore
- Director term end
- 1 August 2026